The American Society of Colon and Rectal Surgeons is the premier society for colon and rectal surgeons and other surgeons dedicated to advancing and promoting the science and practice of the treatment of patients with diseases and disorders affecting the colon, rectum and anus.

Amgen is a leading human therapeutics company in the biotechnology industry. For more than 25 years, the company has tapped the power of scientific discovery and innovation to advance the practice of medicine. Amgen strives to serve patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or even save lives.

Biotechnology Industry Organization (BIO)
Bio is the world's largest biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. Our mission is to be the champion of biotechnology and the advocate for our member organizations—both large and small.

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to extend and enhance human life by providing the highest-quality biopharmaceutical products. They are focused on both finding innovative medicines to combat serious diseases and on getting them to patients faster and more efficiently.

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases and other conditions earlier. Their vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention.

Genentech BioOncology is an industry leader in researching the molecular basis of cancer with a long-standing commitment to fundamentally transforming the way cancer is treated. Genentech believes that studying the biological pathways involved in cancer development, progression and metastasis holds the key to identifying promising molecular targets. Genentech BioOncology is focused on both the basic biology of cancer and its application to therapeutics in oncology.

Genomic Health is a life science company founded in August of 2000 and located in Redwood City, California. It is committed to improving the quality of cancer treatment decisions through the research, development and commercialization of genomic-based clinical laboratory services. To that end, the company conducts sophisticated genomic research to develop new tools for diagnosis that provide individualized information on response to certain types of therapy, as well as the likelihood of disease recurrence. This is done through examining the behavior of multiple genes—a process known as genomic analysis— to provide patients and healthcare professionals with a better understanding of what is happening inside the patient’s tumor. These diagnostic technologies generate information that healthcare providers and patients can use in making treatment decisions.

The Medical Imaging & Technology Alliance (MITA), a division of the National Electrical Manufacturers Association (NEMA), is the collective voice of medical imaging equipment manufacturers, innovators, and product developers. It represents companies whose sales comprise more than 90 percent of the global market for medical imaging technology.

Roche is an innovator of products and services for the early detection, prevention, diagnosis and treatment of diseases. They contribute on a broad range of fronts to improving people's health and quality of life. Roche's mission is to create added value in healthcare by focusing on diagnostics and pharmaceuticals.

Sanofi-aventis is a leading global pharmaceutical company that discovers, develops, produces and markets innovative therapies that enhance people's lives. Their extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders and vaccines.

Salix is committed to being the leading U.S. specialty pharmaceutical company licensing, developing and marketing innovative products to healthcare professionals to prevent or treat gastrointestinal disorders in patients while providing rewarding opportunities for our employees and creating exceptional value for our stockholders.

Sirtex Medical Inc is a leading developer of targeted and innovative cancer therapies. Selective Internal Radiation Therapy (SIRT), also known as radioembolization, is a targeted treatment that delivers millions of radioactive beads called SIR-Spheres® microspheres to treat metastatic colorectal cancer. SIRT is an outpatient treatment performed by an interventional radiologist. In clinical studies, SIR-Spheres has been used with modern systemic chemotherapy or as a monotherpay. SIR-Spheres microspheres is a the only FDA approved microsphere for the treatment of metastatic colorectal liver tumors. For more information go to www.sirtex.com.